Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001209191-22-060442

Director acquired 82,987 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Spragens Jeffrey G Director 2022-12-07 Grant or award +82,987 $1.21 $99,999 394,989 D
Derivatives
Spragens Jeffrey G Director 2022-12-07 Grant or award · Warrant (Common Stock) +82,987 82,987 D
Loading xslF345X03/doc4.xml…